Intensive postremission therapy in acute myeloid leukemia. Results of a prospective comparative trial;INTENSIVE POSTREMISSIONSTHERAPIE BEI AKUTER MYELOISCHER LEUKAMIE. ERGEBNISSE EINER PROSPEKTIV VERGLEICHENDEN STUDIE DER SUDDEUTSCHEN HAMOBLASTOSEGRUPPE (SHG)

Medizinische Klinik

Volumn 91, Issue SUPPL. 3, 1996, Pages 26-32

  Hubner, G ^a   Link, H ^a   Schonrock Nabulsi, P ^a   Wandt, H ^a   Gramatzki, M ^a   Loffler, B ^a   Fackler Schwalbe, I ^a   Queisser, W ^a   Brack, N ^a   Geer, T ^a   Raab, M ^a   Ohl, S ^a   Schneider, B ^a   Schneider, C ^a   Freund, M ^a   Poliwoda, H ^a   Ehninger, G ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; COMBINED MODALITY THERAPY; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REMISSION INDUCTION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 9344226184     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)